Delivery Order SPE2DB22D2206-SPE2DB26FDT40
- Not listed
- The Defense Logistics Agency awarded a $22,762.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMMAGARD S-D 10 G, a specialized immunoglobulin therapeutic product. Issued on May 13, 2025, with a completion date of June 4, 2025, this non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $22,762.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for GAMMAGARD S-D 10G on September 22, 2025, with completion required by October 14, 2025. This non-set-aside award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $34,961.10 to AmerisourceBergen Drug Corp for Gammagard Liquid 10% in 200mL vials, with an ultimate completion date of November 17, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency Troop Support Medical awarded a $8,625.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for GAMMAGARD S-D 10 G (IGA) under contract number 4561694902. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The contract period of performance spans from August 3, 2023 to August 24, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support in procurement and supply chain...
- The Defense Logistics Agency awarded a $13,963.20 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of GAMUNEX-C 40 gram/400 milliliter vials with a completion date of September 23, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order is structured as a child contract under AmerisourceBergen's larger...
- This federal contract award, valued at $8,970.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of GAMMAGARD S-D 10 G (IGA), a prescription pharmaceutical product, with a completion date of June 7, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Department of Veterans Affairs...
- The Defense Logistics Agency awarded a delivery order valued at $7,325.64 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 10 gram/100 mL immunoglobulin vial product, with an ultimate completion date of August 21, 2025. This competitive award, issued on July 31, 2025, utilizes a firm fixed price contract type with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $9,308.80 to AmerisourceBergen Drug Corp for the supply of Gamunex-C, a 40-gram immunoglobulin product in 400 mL vials, with performance through September 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's extensive pharmaceutical supply portfolio supporting federal medical procurement needs. The contract will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,040.44 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 40-gram/400-milliliter immunoglobulin vial. The contract was competitively awarded without set-aside designation and is scheduled for completion by May 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This delivery order represents a firm fixed price transaction for specialized...
- The Defense Logistics Agency awarded a delivery order valued at $9,522.72 to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 milliliter vials. This is a firm fixed price contract with an ultimate completion date of August 18, 2025, and was competitively awarded without a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDT40Delivery Order
The Defense Logistics Agency awarded a $10,096 delivery order to AmerisourceBergen Drug Corp for GAMMAGARD S-D 10G, a specialized immunoglobulin product used for treating immune deficiency disorders and other immunological conditions. This competitive award, issued on October 23, 2025, with completion targeted for November 14, 2025, reflects a firm fixed-price delivery order structure with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's track record with the DLA demonstrates consistent capability to fulfill federal medical supply requirements through competitive procurement, positioning the company as a key supplier for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 10/23/25 |